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Kathryn B. Garber1,*Risk of Pancreatic Cancer in Lynch Syndrome
Inheritedmutations inmismatch repair genes are associated
with dominantly inherited colon cancer. The shifting of the
name of this cancer syndrome from hereditary nonpolypo-
sis colon cancer back to Lynch syndrome reﬂects the fact
that colon cancer is not the only form of cancer found in
these families. Going back to some of the original families
described by Lynch, one of the other cancers observed is
pancreatic cancer. However, whether the cases of pancreatic
cancer noted in these families were chance events or
whether theywere actually directly related to themismatch
repair defect has not been clear. Kastrinos et al. used two
cancer registries to better estimate the risk of pancreatic
cancer associated with Lynch syndrome. They had data
from over 6000 individuals from 147 families with muta-
tions in one of the mismatch repair genes. Overall, they
observed nearly a 9-fold increased risk of pancreatic cancer
in these families, compared to the general population. The
relative risk is much higher at ages less than 50 years but
then becomes more similar to the general population risk
from ages 50–70. This work indicates that surveillance for
pancreatic cancer in families with Lynch syndrome may
be important, although the beneﬁts and limitations of this
type of surveillance, which may include radiographic and
endoscopic imaging, has not yet been assessed.
Kastrinos et al. (2009). Risk of pancreatic cancer in families
with Lynch syndrome. JAMA 302, 1790–1795.
Speech Networks
Ever since disruptions of FOXP2 were found in individuals
with severe language impairment, there has been research
focused on the idea that if mutations in this single gene
can take away language, perhaps this was a key gene in
the evolution of human language. FOXP2 appears to have
undergone accelerated evolution in the human lineage,
adding fuel to this idea, but no functional roles for the
two human-speciﬁc residues in FOXP2 have been deﬁned.
To dissect out human-speciﬁc roles for FOXP2, Konopka
et al. expressed the human or the chimp form of FOXP2 in
human neuronal cells lacking FOXP2. They compared the
cell lines by using expression arrays and found 116 genes
that were differentially regulated by the human and chimp
proteins. Reporter assayswithpromoters fromeightof these
genes conﬁrmed this differential expression in six cases.
Even more striking is the in vivo evidence demonstrating
that many of these genes are expressed at different levelsThe Americanin human versus chimpanzee brains. The authors surmise
that networks of genes were actually key to the develop-
ment of the language circuitry. They performed network
analysis on the expression data and found two modules of
genes that appear to be driven by the human-chimp differ-
ences in FOXP2. Some of these genes exhibit evidence of
positive selection themselves, providing support for the
idea that a coevolving gene network that included FOXP2
might have been key to human speech development.
Konopka et al. (2009). Human-speciﬁc transcriptional regu-
lation of CNS development genes by FOXP2. Nature 462,
213–218.
I’m Beginning to See the Light
Gene therapy seems to be the big promise that continually
stays just over the horizon. The horizon seems like it just
got closer with the report by Maguire et al. of their phase 1
trial of gene therapy for Leber’s congenital amaurosis, an in-
herited retinal degeneration. In this trial, 12 patients with
mutations in RPE65, ranging in age from 8 to 44 years, had
injections of a gene therapy vector expressing RPE65 into
their most severely affected eye. All of the treated patients
had stable improvements in retinal function in the treated
eye, including improved visual ﬁeld and pupillary light
responses, andmost patients had reductions in nystagmus.
The greatest improvements were seen in children, presum-
ablybecause retinaldegeneration isnotaswidespreadearlier
in life. In fact, an8-year-old child in the trial achievednearly
the same light sensitivity as age-matched control individ-
uals.Videoclips in thesupplementaldata showa remarkable
improvement in one particular child’s ability to navigate an
obstacle course in dim light. These indications of treatment
efﬁcacy, coupled with a lack of adverse events, set the path
for expanding this trial. Could we ﬁnally be seeing the light
at the end of the tunnel for gene therapy?
Maguire et al. (2009). Age-dependent effects of RPE65 gene
therapy for Leber’s congenital amaurosis: A phase 1 dose-esca-
lation trial. The Lancet 374, 1597–1605.
Cultural Evolution
More than 20 years ago, Richard Lenski started growing
a single clone of E. coli in glucose-limiting medium. This
culture has been kept going continuously since that day
with daily transfer to fresh medium. At regular intervals,
samples of this culture were frozen away until over
40,000 generations had passed, providing a wonderful1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA
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system in which to study the evolution of a model
organism. This group has now used next generation
sequencing technologies to compare the complete
genomes of clones that span the generations back to the
ancestor. Over the ﬁrst 20,000 generations, 45 mutations
arose at a nearly linear rate, which would suggest neutral
evolution. One might expect that changes in ﬁtness would
go hand in hand with changes to the genome, so you
would also see a steady increase in ﬁtness over time.
However, their measures of ﬁtness suggest that beneﬁcial
mutations appeared rapidly early in the culture, but this
rate declined over time. Even in this simple system with
a model organism and a constant environment, the rela-
tionship between genomic and adaptive evolution is not
as straightforward as we might have assumed.
Barrick et al. (2009). Genome evolution and adaptation in
a long-term experiment with Escherichia coli. Nature 461,
1243–1249.
A Smaller, Recurrent Deletion at Chromosome
15q13.3
Recurrent deletions of chromosome 15q13.3 were discov-
ered over the last couple of years and found to be associated760 The American Journal of Human Genetics 85, 759–761, Decemwith a range of phenotypes from epilepsy to schizophrenia
tomental retardation and autism. The deletions result from
nonallelic homologous recombination between low-copy-
repeat elements in the regionand include six genes. Shinawi
et al. now report a smaller recurrent deletion in the same
region that narrows the focus to one likely candidate gene,
CHRNA7. Ten individuals from four families carried this
680 kb deletion, and it was associated with similar pheno-
types to the larger deletion, including mental retardation,
epilepsy, and global developmental delay. The 680 kb dele-
tionwas found in ~1 in 3000 individuals tested and appears
to result from nonallelic homologous recombination
between the ‘‘normal’’ and inverted variant of chromosome
15q13 in heterozygous individuals. Because the smaller
deletion only encompasses two genes, CHRNA7 and
OTUD7A, and because CHRNA7 is an ion channel that has
been implicated in epilepsy and schizophrenia, the authors
propose that haploinsufﬁciency for this gene might be key
to the phenotype and a plausible therapeutic target.
Shinawi et al. (2009). A small recurrent deletion within
15q13.3 is associated with a range of neurodevelopmental
phenotypes. Nat. Genet, in press. Published online November
8, 2009. 10.1038/ng.481.This Month in Our Sister JournalsInterpreting Copy Number Variation
Compared to G-banded karyotypes, comparative genomic
hybridization (CGH)arrayshave givenusmuchﬁner resolu-
tion for detecting copy number changes (CNCs) on
a genome-wide level. But, of course, the more you look for
changes, themore you ﬁnd. There are a few different factors
that one can use to determine whether a CNC is benign or
pathogenic, including its size andgenecontent andwhether
it was inherited or de novo. Still, there isn’t a systematicway
of making this call. To assess variability in interpretation of
CGH array results, Tsuchiya et al. asked 11 different clinical
laboratories to interpret the signiﬁcance of 13 different
CNCs. Not a single test result was interpreted with 100%
agreement. Although there may be common logic toward
the interpretation of CNCs, many aspects of test interpreta-
tion were different, from the fact that number of classiﬁca-
tion categories (normal, abnormal, uncertain clinical signif-
icance, etc.) varied between the labs to the fact that size
cutoffs for reporting CNCs ranged from 50 Kb to 500 Kb.
The authors argue several points that could increase the in-
terlab consistency in CNC interpretation, and these include
theneed for a goodpublicdatabaseofCNCs towhichall labs
could compare their test results, common guidelines for
CNCinterpretationand lab report content, andadesignated
set of classiﬁcation categories for CNCs.
Tsuchiya et al. (2009). Variability in interpreting and report-
ing copy number changes detected by array-based technology inclinical laboratories. Genet. Med., in press. Published online
November 6, 2009. 10.1097/GIM.0b013e3181c0c3b0.
If You Thought Human Centromeres Were Difﬁcult
to Sequence, Try Wheat
We’ve completed the human genome sequence, so you
might think that we could sequence any species’ genome
if we put our mind to it. Taking a human-centric view of
the world, we’re the most complicated organism, so ours
should be the most complicated genome to get through,
right? Not so. The wheat genome has proven to be a very
difﬁcult challenge. In addition to the fact that it is about
17 gigabases in size, it is a hexaploid organism with essen-
tially three genomes within a genome, and these are
referred to as the A, B, and D genomes. The three genomes
arose from the hybridization of three related species of
wild grasses. Each of these genomes is similar but not iden-
tical. Further complicating matters is the fact that ~90% of
the wheat genome is repetitive. Maybe one of the hardest
regions of any genome to sequence is the centromeres
because of their repetitive nature. Qi et al. started to tackle
the wheat centromeres, making use of the fact that some
of the centromeres from rice have been assembled and
that wheat and rice are evolutionarily related. Some rice
centromeres actually contain genes. Qi et al. mapped genes
from rice centromere 8 onto the wheat genome, and they
were aided by the fact that there is an extensive set of wheatber 11, 2009
aneuploid stocks that canbeused to tease apart theA, B, and
D genomes. This work gives us a picture of the evolution of
the cereal chromosome centromeres, and it also outlines
a general approach to deciphering other parts of the wheat
genome, a problem that I am glad I don’t have to tackle!The AmericanQi et al. (2009). A molecular-cytogenetic method for locating
genes to pericentromeric regions facilitates a genome-wide
comparison of synteny between the centromeric regions of wheat
and rice. Genetics, in press. Published online September 21,
2009. 10.1534/genetics.109.107409.Journal of Human Genetics 85, 759–761, December 11, 2009 761
